Liquidia Technologies, Research Triangle Park, N.C.-based biotechnology company, has announced that it will be presenting two preclinical poster presentations at the Association for Research in Vision and Ophthalmology 2013 annual meeting.
The presentations are titled "Application of PRINT Microparticle and Nanoparticle Technology Toward Preparation of Ophthalmic Suspension Formulations With Improved Tolerability and Efficacy" and "Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone."
More Articles on Ophthalmology:
American Academy of Ophthalmology Grants US Rep. Marsha Blackburn Visionary Award
How Ophthalmologists are Affected by Healthcare Cost Changes: 15 Statistics
Liquidia Technologies to Develop Ophthalmology-Focused Company
The presentations are titled "Application of PRINT Microparticle and Nanoparticle Technology Toward Preparation of Ophthalmic Suspension Formulations With Improved Tolerability and Efficacy" and "Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone."
More Articles on Ophthalmology:
American Academy of Ophthalmology Grants US Rep. Marsha Blackburn Visionary Award
How Ophthalmologists are Affected by Healthcare Cost Changes: 15 Statistics
Liquidia Technologies to Develop Ophthalmology-Focused Company